These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 3342254)

  • 1. Inhibition of bone resorption in vitro by serine-esterase inhibitors.
    Lerner UH; Gustafson GT
    Biochim Biophys Acta; 1988 Feb; 964(2):129-36. PubMed ID: 3342254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
    Lerner UH
    J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro.
    Lerner UH; Fredholm BB; Ransjö M
    Biochem J; 1986 Dec; 240(2):529-39. PubMed ID: 3028378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitro.
    Lerner UH; Larsson A
    Bone; 1987; 8(3):179-89. PubMed ID: 2955802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholera toxin on cyclic AMP accumulation and bone resorption in cultured mouse calvaria.
    Ransjö M; Lerner UH
    Biochim Biophys Acta; 1987 Oct; 930(3):378-91. PubMed ID: 2820504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro.
    Lerner UH; Ransjö M; Ljunggren O
    Calcif Tissue Int; 1987 Jun; 40(6):323-31. PubMed ID: 2440532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies on bone resorption in neonatal mouse calvariae using a modified dissection technique giving four samples of bone from each calvaria.
    Ljunggren O; Ransjö M; Lerner UH
    J Bone Miner Res; 1991 Jun; 6(6):543-50. PubMed ID: 1887817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifications of the mouse calvarial technique improve the responsiveness to stimulators of bone resorption.
    Lerner UH
    J Bone Miner Res; 1987 Oct; 2(5):375-83. PubMed ID: 3455622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids hydrocortisone and dexamethasone.
    Conaway HH; Grigorie D; Lerner UH
    J Bone Miner Res; 1996 Oct; 11(10):1419-29. PubMed ID: 8889841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation and bone metabolism: some characteristics of the bone resorptive effect of thrombin in mouse calvarial bones in vitro.
    Lerner UH; Gustafson GT
    Biochim Biophys Acta; 1988 Mar; 964(3):309-18. PubMed ID: 3126818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between bone resorption and lysosomal enzyme release as demonstrated by the effect of 1 alpha-hydroxy-vitamin D-3 in an organ culture system.
    Lerner U
    Biochim Biophys Acta; 1980 Oct; 632(2):204-13. PubMed ID: 7417523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C, and inhibitor of bone resorption produced by osteoblasts.
    Lerner UH; Johansson L; Ranjsö M; Rosenquist JB; Reinholt FP; Grubb A
    Acta Physiol Scand; 1997 Sep; 161(1):81-92. PubMed ID: 9381954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of diphenylhydantoin on lysosomal enzyme release during bone resorption in vitro.
    Lerner U; Hänström L
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):144-50. PubMed ID: 6776782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the effects of cyclic nucleotide phosphodiesterase inhibitors on bone resorption and cyclic AMP formation in vitro.
    Lerner U; Ransjö M; Fredholm BB
    Biochem Pharmacol; 1986 Dec; 35(23):4177-89. PubMed ID: 2431692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy.
    Lerner UH; Grubb A
    J Bone Miner Res; 1992 Apr; 7(4):433-40. PubMed ID: 1319105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of 1 alpha-hydroxy-vitamin D3 stimulated bone resorption in tissue culture by the calcium antagonist verapamil.
    Lerner U; Gustafson GT
    Eur J Clin Invest; 1982 Apr; 12(2):185-90. PubMed ID: 6807691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin stimulates bone resorption and lysosomal-enzyme release in cultured mouse calvaria.
    Gustafson GT; Lerner U
    Biochem J; 1984 Apr; 219(1):329-32. PubMed ID: 6721862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of bone resorption and cell proliferation in vitro by human gingival fibroblasts from patients with periodontal disease.
    Lerner UH; Hänström L; Sjöström S
    Bone Miner; 1990 Sep; 10(3):225-42. PubMed ID: 2224207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of hydrocortisone, parathyroid hormone and the bisphosphonate, APD, on bone resorption in neonatal mouse calvaria.
    Reid IR; Katz JM; Ibbertson HK; Gray DH
    Calcif Tissue Int; 1986 Jan; 38(1):38-43. PubMed ID: 3079651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanisms by which 2-chloroadenosine stimulates bone resorption in tissue culture.
    Lerner U; Fredholm BB
    Biochim Biophys Acta; 1983 May; 757(2):226-34. PubMed ID: 6405798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.